Table 4 Prevalence of Helicobacter pylori (H. pylori) antigen in different METAVIR fibrosis stages in patients with hepatitis C
From: Prevalence of Helicobacter pylori infection in patients with chronic hepatitis C
Fibrosis stages | H. pylori prevalence | Odds ratio, P | X2, P | |
|---|---|---|---|---|
Negative | Positive | |||
No fibrosis (F0) vs. fibrosis (F1‑F3) | ||||
 F0 (n = 95) | 63 (66.32%) | 32 (33.68%) | 1.5, P > 0.05 | 2.3, P > 0.05 |
 F1‑F3 (n = 90) | 50 (55.55%) | 40 (44.45%) | ||
Fibrosis (F1‑F3) vs. cirrhosis (F4) | ||||
 F1‑F3 (n = 90) | 50 (55.55%) | 40 (44.45%) | 3.19, P = 0.001* | 11.4, P = 0.001* |
 F4 (n = 64) | 18 (28.12%) | 46 (71.88%) | ||
Non cirrhosis (F0‑F3) vs. cirrhosis (F4) | ||||
 F0‑F3 (n = 185) | 113 (61.08%) | 72 (38.92%) | 4.0, P < 0.0001* | 20.71, P < 0.0001* |
 F4 (n = 64) | 18 (28.12%) | 46 (71.88%) | ||